Anticonvulsant activity and inhibition of respiration in rat brain homogenates by substituted oxadiazoles.
D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology*; D001921:Brain / Q000378:metabolism*; D003500:Cyclization; D003864:Depression, Chemical; D005260:Female; D066298:In Vitro Techniques; D007656:Ketoglutaric Acids / Q000378:metabolism; D008297:Male; D051379:Mice; D009207:Myoclonus / Q000517:prevention & control; D009243:NAD / Q000378:metabolism; D010069:Oxadiazoles / Q000138:chemical synthesis / Q000494:pharmacology*; D010084:Oxidation-Reduction; D010101:Oxygen Consumption / Q000187:drug effects*; D010433:Pentylenetetrazole / Q000037:antagonists & inhibitors; D011773:Pyruvates / Q000378:metabolism; D051381:Rats; D012663:Semicarbazides / Q000494:pharmacology; D013386:Succinates / Q000378:metabolism
D000927:Anticonvulsants; D007656:Ketoglutaric Acids; D010069:Oxadiazoles; D011773:Pyruvates; D012663:Semicarbazides; D013386:Succinates; D009243:NAD; D010433:Pentylenetetrazole